Fortunately for cystic fibrosis patients, scientists’ understanding of mutations that cause cystic fibrosis has increased tremendously over the past few decades. This has allowed scientists to develop new drugs that bind to some mutant CFTR channels and correct their function. For patients with the treatable mutations, this means that their lung functions are improved. They can also expect to live longer, healthier lives. Great hope exists even for patients with mutations that are not yet correctable with these drugs. Because scientists now understand what causes cystic fibrosis, researchers around the world are continuing to work on new drugs. These would be efficacious for all cystic fibrosis patients. They are using new technologies, such as gene editing and RNAi to solve a great medical challenge.

6.
4pts
Suppose a company develops a new drug that can treat some cystic fibrosis patients who currently have no treatment options. What factors should the company consider when determining the price of the drug? Present two considerations that the company should analyze when developing the price. Explain why each of these considerations is important.